The ACME Laboratories Ltd. (DSE:ACMELAB)
Bangladesh · Delayed Price · Currency is BDT 76.50
-0.10 (-0.13%)
At close: May 6, 2026
The ACME Laboratories Market Cap
The ACME Laboratories has a market cap or net worth of 16.21 billion as of May 6, 2026. Its market cap has increased by 4.08% in one year.
Market Cap
16.21B
Enterprise Value
36.63B
Revenue
38.86B
Ranking
n/a
PE Ratio
6.32
Stock Price
76.50
Market Cap Chart
Since June 8, 2016, The ACME Laboratories's market cap has decreased from 23.61B to 16.21B, a decrease of -31.36%. That is a compound annual growth rate of -3.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 16.19B | 7.90% |
| Dec 30, 2025 | 15.00B | -5.59% |
| Dec 30, 2024 | 15.89B | -11.65% |
| Dec 28, 2023 | 17.99B | - |
| Dec 29, 2022 | 17.99B | -1.73% |
| Dec 30, 2021 | 18.30B | 15.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 56.21B |
| Renata | 47.62B |
| Unilever Consumer Care | 39.85B |
| Beacon Pharmaceuticals | 24.09B |
| Asiatic Laboratories | 13.56B |
| The IBN SINA Pharmaceutical Industry | 9.59B |
| Navana Pharmaceuticals | 6.32B |
| Orion Pharma | 6.22B |